Eli Lilly's stock price has over-corrected following a downgrade in its outlook following the adjustment for acquisition ...

Eli Lilly (NYSE:LLY) announced a significant global licensing and research collaboration with Juvena Therapeutics to explore AI-driven drug candidates for muscle health. This innovative move ...

Savings concept - Piggy bank on US nickel coins] PM Images This week's dividend activity included increased payouts from General Mills (GIS [ and Worthington Enterprises (WOR [ as well as declarations ...

Eli Lilly has a very high P/E ratio of 62, which is more than double the average for the sector. Based on this, the shares look expensive but it is worth considering despite the premium.

Benzinga Bulls And Bears: Eli Lilly, Okto, McDonalds — And Israel-Iran Conflict Sparks Oil Surge by Benzinga Senior Editor Follow Add Comment ...

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...

With the notable exceptions of Novo Nordisk A/S (NYSE: NVO) and Eli Lilly & Co. (NYSE: LLY), biotechnology stocks had a rough ...

Stocks rose Monday, with oil prices declining, following a restrained response by Iran to U.S. attacks over the weekend.

Asian shares are mixed and oil prices have advanced after the escalation of conflict in the Middle East hit Wall Street. Japan reported that its exports fell in May as the auto industry was hit ...

The timing is also interesting. GLP-1s are Novo Nordisk's biggest and fastest-growing revenue stream, and competition is heating up. Eli Lilly's Zepbound is gaining traction, compounded access is ...

U.S. stocks slumped under the weight of a jump for the price of oil. The S&P 500 fell 0.8% Tuesday following signals that ...